Zolbetuximab,Abbexa,abx831434
Zolbetuximab is a monoclonal antibody biosimilar expressed in CHO cells, targeting CLDN18, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications. Zolbetuximab is under investigation in clinical trial NCT01630083 (Efficacy and Safety of IMAB362 in Combination With the EOX Regimen for CLDN18. 2-positive Gastric Cancer).
Host
Human, Mouse
Reactivity
Human
Application
ELISA, WB
Conjugate
Unconjugated
Platform ID
BAB672671890
Abbexa
Contact
Tel: +44 (0) 1223 755950
Fax: +44 (0) 1223 755951
Email:
Product Specifications
Specifications
NameZolbetuximab
Cat. No.abx831434
HostHuman, Mouse
IsotypeIgG1 Kappa
ReactivityHuman
ConjugationUnconjugated
ApplicationELISA, WB
Working DilutionsOptimal dilutions/concentrations should be determined by the end user.
ClonalityMonoclonal
ConcentrationBatch-dependent, typically between 0.5-2.0 mg/ml.
TargetCLDN18
PurityPurified from cell culture supernatants by Protein A/G chromatography.
Appearance/FormLiquid
Formulation0.01 M PBS. pH 7.4.
StorageAliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
Regulatory StatusResearch Use Only
Category Paths
- Products>Primary Antibodies>Biosimilar Antibodies
Request a product
Please provide the required information below so that we can quickly source your products.